Benzinga · Nov 11, 2026
NEXGEL Advances Recapitalization As Noteholders Agree To Convert $14.1M Of Debt
Approximately 95% of Outstanding Convertible Note Principal Committed to Conversion, Subject to Completion of a Strategic MergerSequence LifeScience™ Provides $732,000, Representing 61% of Approximately $1.2 Million

